πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9085578

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9079907

Fused heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9073864

Aromatic ring compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9073918

Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066936

Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9060941

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056873

Substituted 6-aza-isoindolin-1-one derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044483

Cell death inhibition by macrophage migration inhibitory factor and a binding substance th

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9045496

N-substituted oxazinopteridines and oxazinopteridinones

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9045436

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9040522

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

Takeda Pharmaceutical Company Limited Β· Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9029536

Fused heterocyclic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9029388

Condensed heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9023858

Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018374

Crystal of amide compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012447

5-HT3 receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9011926

Method for producing granules

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9006201

Prophylactic or therapeutic agent for diabetes

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8993598

Pyrrole compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8980322

Controlled release composition

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8980902

Poly (ADP-ribose) polymerase (PARP) inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8969387

Pyrrole compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8957070

Glucokinase activator compounds, methods of activating glucokinase and methods of treating

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8957069

Benzofuran derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted